or
forgot password
  • cancer clinical trials in los angeles, CA

  • N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Neuroblastoma
    Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Multiple Myeloma and Plasma Cell Neoplasm
    BAY 43-9006 in Treating Patients With Imatinib Mesylate-Resistant Chronic Phase Chronic Myelogenous Leukemia
    Jonsson Comprehensive Cancer Center, UCLA
    Los Angeles, California 90095-1781
    Leukemia
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Leukemia
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Trial Locations
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Childrens Hospital Los Angeles
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Jonsson Comprehensive Cancer Center, UCLA

    Trial Locations
    Jonsson Comprehensive Cancer Center, UCLA
    Children's Hospital Los Angeles
    Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
    Kidney Cancer
    CpG 7909 in Treating Patients With Cutaneous T-Cell Lymphoma
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Lymphoma
    ZD6474, Carboplatin, and Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Lung Cancer
    SU011248 in Treating Women With Metastatic Breast Cancer That Did Not Respond to Anthracycline or Taxane Chemotherapy
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Breast Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Jonsson Comprehensive Cancer Center at UCLA

    Trial Locations
    Jonsson Comprehensive Cancer Center at UCLA
    Childrens Hospital Los Angeles
    Leukemia
    Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Lung Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Trial Locations
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Jonsson Comprehensive Cancer Center at UCLA
    Childrens Hospital Los Angeles
    Leukemia
    Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)
    Cedars-Sinai Medical Center (Adult Site)
    Los Angeles, California 90048
    Myositis, Dermatomyositis, Polymyositis, Juvenile Dermatomyositis
    Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Cutaneous Melanoma
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    Kaiser Permanente Los Angeles Medical Center
    Jonsson Comprehensive Cancer Center
    Kaiser Permanente Medical Care Program - Los Angeles Medical Center & Sunset Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temozolomide and Radiation Therapy in Treating Patients With Gliomas
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Brain and Central Nervous System Tumors
    Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Colorectal Cancer
    Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Los Angeles, California 90048-1865
    Breast Cancer
    131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
    Cedars-Sinai Medical Center
    Los Angeles, California 90048
    Malignant Glioma, Glioblastoma Multiforme, GBM, Anaplastic Astrocytoma, Oligo-Astrocytoma, Gliosarcoma
    Scleroderma: Cyclophosphamide or Transplantation (SCOT)
    City of Hope National Medical Center

    Trial Locations
    City of Hope National Medical Center
    UCLA Medical School
    Scleroderma, Systemic, Sclerosis, Autoimmune Disease
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Ucla Dept. Of Medicine
    Los Angeles, California 90095
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    Ucla Dept. Of Medicine
    Los Angeles, California 90095
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Suberoylanilide Hydroxamic Acid in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Lymphoma
    Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Los Angeles, California 90048-1865
    Breast Cancer
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Metropolitan Hematology Oncology Medical Group
    Los Angeles, California 90057
    Chronic Lymphocytic Leukemia
    Radiofrequency Ablation in Treating Patients With Liver Cancer and Cirrhosis
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Trial Locations
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Jonsson Comprehensive Cancer Center at UCLA
    Liver Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    David Geffen School of Medicine at UCLA
    Los Angeles, California 90095
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Metastatic Cancer, Prostate Cancer
    Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
    USC/Norris Comprehensive Cancer Center
    Los Angeles, California 90033-0800
    Urologic Neoplasms
    Vitamin D/Calcium Polyp Prevention Study
    University of Southern California
    Los Angeles, California 90033
    Colorectal Cancer, Polyps, Adenomas
    Phase I/II Study of Celebrex and EPO906 in Patients With Metastatic Colorectal Cancer
    U.S.C./Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Colon Cancer, Colorectal Cancer
    A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
    USC/Norris Comprehensive Cancer Center

    Trial Locations
    USC/Norris Comprehensive Cancer Center
    The Angeles Clinic & Research Inst.
    Melanoma
    Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
    Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Testicular Cancer, Germ Cell Neoplasm
    Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma
    University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Gastric Cancer, Esophageal Neoplasms
    A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
    U.S.C. / Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Hepatocellular Carcinoma, Liver Cancer
    Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
    U.S.C./Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Gastric Cancer, Esophageal Cancer
    Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Non-Hodgkin's Lymphoma
    Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
    Norris Comprehensive Cancer Center
    Los Angeles, California 90033
    Renal Cell Cancer
    Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
    University of California Los Angeles
    Los Angeles, California 90095-6951
    Brain Cancer, Arthritis, Rheumatoid, Central Nervous System Neoplasms, Glioma
    Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia
    City of Hope National Medical Center
    Los Angeles, California 91010
    Leukemia, Myelocytic, Acute
    Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299)
    UCLA Medical Center
    Los Angeles, California 90095-7059
    Breast Cancer
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    UCLA Medical Center
    Los Angeles, California 90095-7059
    Colorectal Cancer
    Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone Involvement
    Children's Hospital Los Angeles
    Los Angeles, California 90027-0700
    NEUROBLASTOMA